CIBINQO (abrocitinib) pill held between fingers

CIBINQO (abrocitinib) pill held between fingers

HOW CIBINQO WORKS

CIBINQO works below the surface to fight moderate-to-severe eczema

CIBINQO is a different kind of eczema treatment called a JAK inhibitor. A JAK inhibitor works by disrupting a process that can lead to inflammation and itch. Take a closer look below.

mechanism of action video animation

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      CIBINQO in action

      • What causes eczema icon

        IRREGULAR IMMUNE RESPONSE

        Eczema may occur because of irregular immune responses that take place within the body.

        Some proteins that play a role in this overactive immune response are called JAKs. Increased JAK activity is thought to contribute to your skin becoming inflamed.

      • How does CIBINQO (abrocitinib) work icon

        CIBINQO BLOCKS JAK1 ACTIVITY

        CIBINQO is a type of eczema treatment known as a JAK inhibitor. It blocks JAK1 activity, interrupting one of the processes that leads to inflammation.

      • How does CIBINQO (abrocitinib) work icon

        LESS INFLAMMATION

        Less inflammation can mean less itch and clearer skin.

      It's not currently known how inhibiting specific JAK proteins can affect eczema.

      Looking for proven eczema relief?

      See how CIBINQO provided fast itch relief and clearer skin for some people (ages 12 years and older) in clinical trials.

      Show the resultsTeen study results

      Connect with a nearby doctor

      Schedule an appointment with your doctor today. If you don’t have one yet, you can find one using this tool.

      Find a doctor

      Pfizer Dermatology Patient Access logo

      Patient Support Representative icon

      With you every step of the way, offering savings and personalized support for your Pfizer dermatology medication.

      1-833-956-DERM (1-833-956-3376)
      Monday-Friday, 8 AM-8 PM ET

      Visit PfizerDermatologyPatientAccess.com

      Eligibility required for financial assistance.

      You are encouraged to report adverse events related to Pfizer products by calling 1-800-438-1985 (U.S. only).

      If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.